{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:17:11Z","timestamp":1793305031828,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":114,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100015074","name":"Schweizerische Studienstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015075","name":"Janggen-P\u00f6hn-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015075","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University College London Overseas Research Scholarship"},{"name":"NIH","award":["EY019014"],"award-info":[{"award-number":["EY019014"]}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001205","name":"F. M. Kirby Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s13311-023-01378-0","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T23:02:55Z","timestamp":1683759775000},"page":"1138-1153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Nanoparticles Enhance Solubility and Neuroprotective Effects of Resveratrol in Demyelinating Disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Ehtesham","family":"Shamsher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reas S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Dine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vy","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyanarayana","family":"Somavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Francesca","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2417-258X","authenticated-orcid":false,"given":"Kenneth S.","family":"Shindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-023-01378-0_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"key":"10.1007\/s13311-023-01378-0_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fneur.2012.00084","article-title":"Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis","volume":"3","author":"Fonseca-Kelly","year":"2012","journal-title":"Front Neurol"},{"key":"10.1007\/s13311-023-01378-0_bib3","first-page":"1","article-title":"The therapeutic potential of resveratrol: a review of clinical trials","volume":"11","author":"Berman","year":"2017","journal-title":"NPI Precis Oncol"},{"key":"10.1007\/s13311-023-01378-0_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/nu8040200","article-title":"Resveratrol and ophthalmic diseases","volume":"8","author":"Abu-Amero","year":"2016","journal-title":"Nutrients"},{"key":"10.1007\/s13311-023-01378-0_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exger.2018.09.019","article-title":"Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials","volume":"113","author":"Drygalski","year":"2018","journal-title":"Exp Gerontol"},{"key":"10.1007\/s13311-023-01378-0_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/17469899.2019.1604222","article-title":"Neuroprotection in glaucoma: Old concepts, new ideas","volume":"14","author":"Shamsher","year":"2019","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1007\/s13311-023-01378-0_bib7","series-title":"Progress in Brain Research","first-page":"119","article-title":"Naturally occurring neuroprotectants in glaucoma","author":"Patel","year":"2020"},{"key":"10.1007\/s13311-023-01378-0_bib8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/toxsci\/kfh263","article-title":"Resveratrol-associated renal toxicity","volume":"82","author":"Crowell","year":"2004","journal-title":"Toxicol Sci"},{"key":"10.1007\/s13311-023-01378-0_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jddst.2019.03.017","article-title":"Drug delivery systems for resveratrol, a non-flavonoid polyphenol: Emerging evidence in last decades","volume":"51","author":"Ahmadi","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1007\/s13311-023-01378-0_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29393-8","article-title":"Topical curcumin nanocarriers are neuroprotective in eye disease","volume":"8","author":"Davis","year":"2018","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-023-01378-0_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm Res"},{"key":"10.1007\/s13311-023-01378-0_bib12","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/smll.201303433","article-title":"Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes","volume":"10","author":"Davis","year":"2014","journal-title":"Small"},{"key":"10.1007\/s13311-023-01378-0_bib14","article-title":"Intranasal delivery of a novel amnion cell secretome prevents neuronal damage and preserves function in a mouse multiple sclerosis model","volume":"7","author":"Khan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-023-01378-0_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243862","article-title":"Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells","volume":"16","author":"Willett","year":"2021","journal-title":"PLoS ONE"},{"issue":"18","key":"10.1007\/s13311-023-01378-0_bib16","first-page":"448","article-title":"Amnion-derived multipotent progenitor cells suppress experimental optic neuritis and myelitis","volume":"181","author":"Khan","year":"2020","journal-title":"Neurother"},{"key":"10.1007\/s13311-023-01378-0_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejps.2013.02.006","article-title":"The applications of vitamin e TPGS in drug delivery","volume":"49","author":"Guo","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1007\/s13311-023-01378-0_bib18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jsps.2018.03.009","article-title":"Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells","volume":"26","author":"Nassir","year":"2018","journal-title":"Saudi Pharm J"},{"key":"10.1007\/s13311-023-01378-0_bib19","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.181457","article-title":"Resveratrol-loaded PLGA nanoparticles: Enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy","volume":"5","author":"Wan","year":"2018","journal-title":"R Soc Open Sci"},{"key":"10.1007\/s13311-023-01378-0_bib20","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.2147\/IJN.S257269","article-title":"The influence of nanoparticle properties on oral bioavailability of drugs","volume":"15","author":"Wang","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1007\/s13311-023-01378-0_bib21","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.foodres.2014.05.059","article-title":"Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol","volume":"62","author":"Pandita","year":"2014","journal-title":"Food Res Int"},{"key":"10.1007\/s13311-023-01378-0_bib22","first-page":"183","article-title":"Polycaprolactone scaffold engineered for sustained release of resveratrol: Therapeutic enhancement in bone tissue engineering","volume":"9","author":"Kamath","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1007\/s13311-023-01378-0_bib23","doi-asserted-by":"crossref","first-page":"50336","DOI":"10.1039\/C6RA10777J","article-title":"Intravenous administration of: Trans -resveratrol-loaded TPGS-coated solid lipid nanoparticles for prolonged systemic circulation, passive brain targeting and improved in vitro cytotoxicity against C6 glioma cell lines","volume":"6","author":"Vijayakumar","year":"2016","journal-title":"RSC Adv"},{"key":"10.1007\/s13311-023-01378-0_bib24","doi-asserted-by":"crossref","first-page":"74254","DOI":"10.1039\/C6RA15408E","article-title":"Resveratrol loaded PLGA:D-\u03b1-tocopheryl polyethylene glycol 1000 succinate blend nanoparticles for brain cancer therapy","volume":"6","author":"Vijayakumar","year":"2016","journal-title":"RSC Adv"},{"key":"10.1007\/s13311-023-01378-0_bib25","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.2147\/IJN.S164235","article-title":"Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: Enhanced bioavailability and in vitro anti-inflammatory activity","volume":"13","author":"Siu","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1007\/s13311-023-01378-0_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2051-5960-2-3","article-title":"SIRT1 Activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease","volume":"2","author":"Khan","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-023-01378-0_bib27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1167\/iovs.06-0553","article-title":"Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis","volume":"48","author":"Qi","year":"2007","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1007\/s13311-023-01378-0_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000267321","article-title":"Role of hydrogen peroxide in experimental optic neuritis","volume":"25","author":"Guy","year":"1993","journal-title":"Ophthalmic Res"},{"key":"10.1007\/s13311-023-01378-0_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/WNO.0b013e3181f7f833","article-title":"Oral resveratrol reduces neuronal damage in a model of multiple sclerosis","volume":"30","author":"Shindler","year":"2010","journal-title":"J Neuro-Ophthalmology"},{"key":"10.1007\/s13311-023-01378-0_bib30","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3389\/fnins.2018.00690","article-title":"Inhibition of NF-\u03baB signaling pathway by resveratrol improves spinal cord injury","volume":"12","author":"Xu","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1007\/s13311-023-01378-0_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/nyas.12819","article-title":"Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation","volume":"1348","author":"Latruffe","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1007\/s13311-023-01378-0_bib32","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1007\/s12035-016-9891-5","article-title":"Resveratrol promotes remyelination in cuprizone model of multiple sclerosis: Biochemical and histological study","volume":"54","author":"Ghaiad","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1007\/s13311-023-01378-0_bib33","article-title":"SIRT1 activation confers neuroprotection in experimental optic neuritis","volume":"48","author":"Shindler","year":"2007","journal-title":"Investig Opthalmology Vis Sci"},{"key":"10.1007\/s13311-023-01378-0_bib34","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1167\/iovs.17-22972","article-title":"SIRT1 and NRF2 gene transfer mediate distinct neuroprotective effects upon retinal ganglion cell survival and function in experimental optic neuritis","volume":"59","author":"McDougald","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1007\/s13311-023-01378-0_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060830","article-title":"Selective Upregulation of SIRT1 expression in retinal ganglion cells by AAV-mediated gene delivery increases neuronal cell survival and alleviates axon demyelination associated with optic neuritis","volume":"12","author":"Ross","year":"2022","journal-title":"Biomolecules"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01378-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-023-01378-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923019165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923019165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01378-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:12:47Z","timestamp":1761808367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923019165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1878747923019165"],"URL":"https:\/\/doi.org\/10.1007\/s13311-023-01378-0","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticles Enhance Solubility and Neuroprotective Effects of Resveratrol in Demyelinating Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-023-01378-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}